This website has been developed and funded by Besins Healthcare (UK).
This website has separate sections for healthcare professionals (containing promotional information), and patients who have been prescribed Oestrogel®(estradiol 0.06% w/w) within the UK.
Imvaggis is indicated for the local treatment of vaginal symptoms of oestrogen deficiency in postmenopausal women11
An ultra-low dose, estriol pessary that is easily inserted without the need for an applicator, designed with the patient in mind11, 12
Imvaggis significantly improves the symptoms of vaginal atrophy vs placebo at 12 weeks (p<0.001)13
The estriol (active ingredient) in Imvaggis is body identical, it is derived from yams and soya and is chemically identical to estriol produced naturally by the body 2, 11, 14
Imvaggis aligns with recommendations to use the lowest effective dose for treatment of vaginal atrophy15
